Background Whether the two drug-eluting stents approved by the US Food and Drug
Administration—a sirolimus-eluting stent and a paclitaxel-eluting stent—are associated with …

Coronary artery stents revolutionized the practice of interventional cardiology after they were
first introduced in the mid-1980s. Since then, there have been significant developments in …

Background—Drug-eluting stents (DES) have been in clinical use for nearly a decade;
however, the relative short-and long-term efficacy and safety of DES compared with bare …

In patients with stable CAD, PCI can be considered a valuable initial mode of
revascularization in all patients with objective large ischaemia in the presence of almost …

Interventions. Copies: This document is available on the World Wide Web sites of the
American College of Cardiology (www. acc. org), American Heart Association (my …

Background Sirolimus-eluting stents and paclitaxel-eluting stents, as compared with bare-
metal stents, reduce the risk of restenosis. It is unclear whether there are differences in …

Objectives To investigate the safety and efficacy of durable polymer drug eluting stents
(DES) and biodegradable polymer biolimus eluting stents (biolimus-ES). Design Network …

Objectives To evaluate the efficacy and safety of currently used drug eluting stents
compared with each other and compared with bare metal stents in patients with diabetes …

ContextCompared with bare metal stents, sirolimus-eluting and paclitaxel-eluting stents
have been shown to markedly improve angiographic and clinical outcomes after …

Objectives: Our purpose was to make a synthesis of the available evidence on the relative
efficacy and safety of 2 drug-eluting stents (DES)—sirolimus-eluting stent (SES) and …